PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.81%
Growth of 1.81% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
-7.28%
Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.
23.28%
Growth of 23.28% versus flat Healthcare gross profit. Walter Schloss would verify quality.
21.09%
Margin change of 21.09% versus flat Healthcare margins. Walter Schloss would verify quality.
135.68%
R&D change of 135.68% versus flat Healthcare spending. Walter Schloss would verify adequacy.
0.96%
G&A change of 0.96% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
7.45%
Marketing expense change of 7.45% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-70.19%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
5.07%
Operating expenses change of 5.07% versus flat Healthcare costs. Walter Schloss would verify control.
-3.48%
Total costs reduction while Healthcare median is -0.67%. Seth Klarman would investigate advantages.
63.11%
Interest expense change of 63.11% versus flat Healthcare costs. Walter Schloss would verify control.
13.90%
D&A change of 13.90% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
22.10%
EBITDA change of 22.10% versus flat Healthcare. Walter Schloss would verify quality.
-43.85%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
119.76%
Income change of 119.76% versus flat Healthcare. Walter Schloss would verify quality.
119.41%
Margin change of 119.41% versus flat Healthcare. Walter Schloss would verify quality.
-65.63%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
12.44%
Income change of 12.44% versus flat Healthcare. Walter Schloss would verify quality.
10.44%
Margin change of 10.44% versus flat Healthcare. Walter Schloss would verify quality.
495.97%
Tax expense change of 495.97% versus flat Healthcare. Walter Schloss would verify strategy.
-0.34%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-2.11%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
5.93%
EPS change of 5.93% versus flat Healthcare. Walter Schloss would verify quality.
7.76%
Diluted EPS change of 7.76% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.